Extended Data Fig. 10: Decreased mitochondria activity by cholestatic DILI drug treatment.
From: Polygenic architecture informs potential vulnerability to drug-induced liver injury
Live staining for TMRM and mitochondria levels (mitotracker) in 1383 iPSC-HLO model under CsA treatment for 72hr.
